Composition
- Active ingredients
- GALANTAMINE HYDROBROMIDE EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- GALANTAMINE HYDROBROMIDE EQ 12MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA021169-003 · Discontinued
- GALANTAMINE HYDROBROMIDE EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA021169-001 · Discontinued
- GALANTAMINE HYDROBROMIDE EQ 8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- GALANTAMINE HYDROBROMIDE 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SolutionNDA021224-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA021169.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Razadyne
- Active substance
- galantamine hydrobromide
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Janssen Pharms
- Status
- Discontinued
- FDA approval
- 28 Feb 2001
- Application
- NDA021169-002